News 21
Oxford Pharmascience: On the road to profitability
January 24th this year was an important landmark for Oxford
Pharmascience (LON:OXP), though it passed with little fanfare.
It marked the date of the company's official launch of its first
licensed product in Brazil by its partner and a significant
milestone along the road to profitability.
The early signs of this can be seen with the first two orders
helping the group lift last year's revenues by over 230 per cent to
£292,000, while a further two orders have been banked already this
year.
The partner is Aché Laboratórios Farmacêuticos, or Aché for
short, one of the largest pharmaceuticalcompanies in Brazil and
which has launched a calcium and vitamin D soft chew using the
company's OXP chew technology.
To read the full article, please click
here
Source - http://www.proactiveinvestors.co.uk/
